SEC Form 4 · accession 0001179110-19-003027
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Visioli
Officer — Chief Financial Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 4, 2019 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right-to-buy)F1 | $25.41 | Mar 1, 2019 | A | 65,000 | A | — | Mar 1, 2029 | Common Stock | 65,000 | 65,000 | D |
Explanation of responses
- F1The option vests in forty-eight equal installments beginning April 1, 2019.